These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 24171963

  • 1. [Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].
    Jin P, Shi J, Li XX, Shao YQ, Nie N, Ge ML, Zhang J, Huang ZD, Huang JB, Zheng YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):877-82. PubMed ID: 24171963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance].
    Qin Y, Liu H, Ruan S, Cai YF, You XF, Song GQ.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):758-61. PubMed ID: 22339912
    [Abstract] [Full Text] [Related]

  • 5. Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up.
    Jin P, Wang J, Li X, Wang M, Ge M, Zhang J, Huang J, Zhang J, Huang Z, Nie N, Shao Y, Shi J, Zheng Y.
    Int J Hematol; 2015 Jan; 101(1):13-22. PubMed ID: 25430083
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of serum transferrin receptor in differential diagnosis of anemia].
    Chen JL, Li SL, Xu M, Wang HB, Ge CW, Li RS.
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):423-5. PubMed ID: 15312435
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study of iron metabolism indicators in ineffective hematopoiesis of myelodysplastic syndrome].
    Yang Y, Yang B, Liang ZP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):948-52. PubMed ID: 23998591
    [Abstract] [Full Text] [Related]

  • 8. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M, Uchiyama T, Okamoto S, Kanakura Y, Sawada K, Tomonaga M, Nakao S, Nakahata T, Harada M, Murate T, Ozawa K, Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.
    Eur J Haematol; 2007 Jun; 78(6):487-94. PubMed ID: 17391310
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor 15 increased in severe aplastic anemia patients.
    Shao Y, Wang H, Liu C, Cao Q, Fu R, Wang H, Wang T, Qi W, Shao Z.
    Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
    [Abstract] [Full Text] [Related]

  • 10. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT.
    Eur J Haematol; 2009 Dec 01; 83(6):565-71. PubMed ID: 19737308
    [Abstract] [Full Text] [Related]

  • 11. [Significance of magnetic resonance imaging in the detection of iron overload].
    Zhang Q, Hou B, Wang L, Wang XY, Feng F, Jiang B, Shi HX, Ma YG, Liu H, Han B, Zhao YQ.
    Zhonghua Yi Xue Za Zhi; 2013 Nov 26; 93(44):3506-9. PubMed ID: 24521890
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Study of abnormal iron metabolism parameters and iron overload in patients with myelodysplastic syndromes].
    Song LL, Zheng QQ, Xiao C, Guo J, Wu D, Su JY, Zhou LY, Chang CK.
    Zhonghua Xue Ye Xue Za Zhi; 2016 Oct 14; 37(10):903-907. PubMed ID: 27801326
    [Abstract] [Full Text] [Related]

  • 14. [Determinants for iron overload in patients with acute leukemias and aplastic anemia].
    Makeshova AB, Levina AA, Mamukova IuI, Tsibul'skaia MM, Makarova PM, Romanova EA, Fevraleva IS, Sudarikov AB, Golovkina LL, Stremoukhova AG, Parovichnikova EN, Savchenko VG.
    Ter Arkh; 2010 Oct 14; 82(7):26-9. PubMed ID: 20853605
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F, Höchsmann B, Giagounidis A, Lübbert M, Platzbecker U, Haase D, Lück A, Gattermann N, Taupitz M, Baier M, Leismann O, Junkes A, Schumann C, Hofmann WK, Schrezenmeier H.
    Ann Hematol; 2013 Jan 14; 92(2):191-8. PubMed ID: 23073603
    [Abstract] [Full Text] [Related]

  • 18. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.
    Biol Blood Marrow Transplant; 2010 Jan 14; 16(1):115-22. PubMed ID: 19766730
    [Abstract] [Full Text] [Related]

  • 19. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ.
    J Pediatr Hematol Oncol; 2009 May 14; 31(5):309-12. PubMed ID: 19415007
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.